HK1165796A1 - Imidazolidine-2,4-dione derivatives and use thereof as a medicament -24- - Google Patents

Imidazolidine-2,4-dione derivatives and use thereof as a medicament -24-

Info

Publication number
HK1165796A1
HK1165796A1 HK12106442.7A HK12106442A HK1165796A1 HK 1165796 A1 HK1165796 A1 HK 1165796A1 HK 12106442 A HK12106442 A HK 12106442A HK 1165796 A1 HK1165796 A1 HK 1165796A1
Authority
HK
Hong Kong
Prior art keywords
imidazolidine
medicament
dione derivatives
dione
derivatives
Prior art date
Application number
HK12106442.7A
Other languages
English (en)
Chinese (zh)
Inventor
Dennis Bigg
Serge Auvin
Christophe Lanco
Grgoire Prevost
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of HK1165796A1 publication Critical patent/HK1165796A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12106442.7A 2009-04-17 2012-07-03 Imidazolidine-2,4-dione derivatives and use thereof as a medicament -24- HK1165796A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901864A FR2944525B1 (fr) 2009-04-17 2009-04-17 Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament
PCT/FR2010/000316 WO2010119194A1 (fr) 2009-04-17 2010-04-16 Dérivés d'imidazolidine-2,4-dione et leur utilisation comme médicament

Publications (1)

Publication Number Publication Date
HK1165796A1 true HK1165796A1 (en) 2012-10-12

Family

ID=41258404

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106442.7A HK1165796A1 (en) 2009-04-17 2012-07-03 Imidazolidine-2,4-dione derivatives and use thereof as a medicament -24-

Country Status (18)

Country Link
US (1) US8624037B2 (es)
EP (1) EP2419422B1 (es)
JP (1) JP5571771B2 (es)
KR (1) KR101699100B1 (es)
CN (1) CN102428079B (es)
AU (1) AU2010238381B2 (es)
BR (1) BRPI1014435A2 (es)
CA (1) CA2758638A1 (es)
DK (1) DK2419422T3 (es)
ES (1) ES2527617T3 (es)
FR (1) FR2944525B1 (es)
HK (1) HK1165796A1 (es)
MX (1) MX2011010691A (es)
PL (1) PL2419422T3 (es)
PT (1) PT2419422E (es)
RU (1) RU2555999C2 (es)
UA (1) UA106884C2 (es)
WO (1) WO2010119194A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3089974B1 (en) * 2013-12-31 2019-02-20 Ipsen Pharma S.A.S. Novel imidazolidine-2,4-dione derivatives
ES2686353T3 (es) * 2013-12-31 2018-10-17 Ipsen Pharma S.A.S. Nuevos derivados de imidazolidino-2,4-diona
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途
CN117186027B (zh) * 2023-09-11 2024-04-19 上海蓝木化工有限公司 一种糖原合酶激酶-3抑制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1906492B2 (de) * 1969-02-10 1980-07-31 Bayer Ag, 5090 Leverkusen Carbonsäure-Derivate enthaltende Hydantoine und Polyhydantoine
US3903053A (en) * 1973-11-20 1975-09-02 Teijin Ltd Process for the preparation of polymers containing divalent hydantoin rings in their main chains
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
EP2061767B1 (de) * 2006-08-08 2014-12-17 Sanofi Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung

Also Published As

Publication number Publication date
EP2419422A1 (fr) 2012-02-22
FR2944525A1 (fr) 2010-10-22
BRPI1014435A2 (pt) 2016-04-12
KR101699100B1 (ko) 2017-01-23
PT2419422E (pt) 2015-01-02
CN102428079B (zh) 2014-04-30
EP2419422B1 (fr) 2014-10-15
MX2011010691A (es) 2011-11-04
ES2527617T3 (es) 2015-01-27
DK2419422T3 (en) 2014-12-15
KR20120027240A (ko) 2012-03-21
US20120095068A1 (en) 2012-04-19
JP2012524051A (ja) 2012-10-11
PL2419422T3 (pl) 2015-04-30
CN102428079A (zh) 2012-04-25
AU2010238381A1 (en) 2011-11-10
UA106884C2 (uk) 2014-10-27
CA2758638A1 (fr) 2010-10-21
RU2011146533A (ru) 2013-05-27
JP5571771B2 (ja) 2014-08-13
US8624037B2 (en) 2014-01-07
RU2555999C2 (ru) 2015-07-10
FR2944525B1 (fr) 2011-06-24
WO2010119194A1 (fr) 2010-10-21
AU2010238381B2 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
HRP20190016T1 (hr) Heterociklički spojevi i njihova upotreba
EP2442647A4 (en) DITHIOL COMPOUNDS, DERIVATIVES AND USES THEREOF
HK1176353A1 (zh) 咪唑烷二酮衍生物
EP2427195A4 (en) HETEROCYCLIC COMPOUNDS AND USES THEREOF
AP2012006216A0 (en) Benzimidazole-imidazole derivatives.
HK1173142A1 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5-
HK1172893A1 (en) 5-fluoropyrimidinone derivatives 5-
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
IL216007A0 (en) Isoxazole-pyridine derivatives
IL213974A0 (en) Isoxazole-isoxazole and isoxazole-isothiazole derivatives
IL215109A0 (en) Isoxazole-pyridazine derivatives
EP2455380A4 (en) Heterocyclic compound and its use
IL214941A0 (en) Isoxazole-pyrazole derivatives
IL213927A0 (en) Deoxyactagardine derivatives
IL218696A0 (en) 2-oxo-1- pyrrolidinyl imidazothiadiazole derivatives
HK1172894A1 (en) N1-acyl-5-fluoropyrimidinone derivatives n1--5-
HK1169623A1 (en) Pyrazinooxazepine derivatives
HK1165796A1 (en) Imidazolidine-2,4-dione derivatives and use thereof as a medicament -24-
IL219872A0 (en) Quinazoline derivatives
GB0922510D0 (en) Compound and use
EP2512482A4 (en) DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE
IL213262A0 (en) Tetrahydronaphthalen-2-ol derivatives
GB0904315D0 (en) Novel imidazole derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives
AU2010238380B2 (en) Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210414